Phosphagenics Limited today announced the initiation of a Phase 1B clinical trial for its patented oxycodone/TPM (Targeted Penetration Matrix) transdermal patch systems.
Read the original post:
Phosphagenics commences Phase 1B clinical trial of its oxycodone/TPM transdermal patch systems (News-Medical-Net)
Tags: clinical-trial, initiation, penetration, the-initiation, today-announced
Alkermes Inc. plans to seek approval next year to market its Vivitrol drug to treat opioid dependence, based on the results of a clinical trial. Cambridge-based Alkermes develops Vivitrol to treat alcoholism.
Tags: based-on-the, clinical-trial, results, vivitrol
Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.
More:
Retigabine’s Phase IIa clinical trial preliminary results announced (News-Medical-Net)
Tags: clinical-trial, federal-priso, former-deputy, retigabine-for, treatment
In the first clinical trial of a medication that was used for an extended time to treat opioid addiction in young adults, participants who received counseling and Suboxone (buprenorphine-naloxone) for 12 weeks had substantially better outcomes than those who received the standard treatment of short-term detoxification and counseling.
Here is the original post:
Extended suboxone treatment substantially improves outcomes for opioid-addicted young adults (News-Medical-Net)
Tags: better-outcomes, clinical-trial, pain clinics, standard